MAIA Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
8.0M
-3.5%
8.3M
+19.7%
6.9M
+61.0%
4.3M
-53.9%
9.4M
R&D
5.3M
-5.4%
5.6M
+60.0%
3.5M
+87.3%
1.9M
-70.4%
6.4M
SG&A
2.7M
+0.4%
2.7M
-21.8%
3.4M
+40.6%
2.4M
-18.9%
3.0M
Operating Income
-8024789
+3.5%
-8317251
-19.7%
-6949929
-61.0%
-4317272
+53.9%
-9360926
EBITDA
-8024789
+3.5%
-8317251
-19.7%
-6949929
-61.0%
-4317272
+53.9%
-9360926
Net Income
-7178137
+9.6%
-7943587
-24.7%
-6369652
-75.5%
-3628762
+59.2%
-8903189
EPS (Basic)
$-0.12
+7.7%
$-0.13
+7.1%
$-0.14
-40.0%
$-0.10
+63.0%
$-0.27
EPS (Diluted)
$-0.12
+7.7%
$-0.13
+7.1%
$-0.14
-40.0%
$-0.10
+63.0%
$-0.27
Shares (Diluted)
60.9M
+0.1%
60.8M
+34.5%
45.2M
+21.3%
37.3M
+12.2%
33.2M
MAIA Biotechnology (MAIA) — Financials